University College Hospital is a teaching hospital in the Fitzrovia area of the London Borough of Camden, England. The hospital, which was founded as the North London Hospital in 1834, is closely associated with University College London, whose main campus is situated next door.

There are 665 beds in University College London Hospital.

During the past decade, University College London Hospital conducted 528 clinical trials. In the 10-year time frame, 528 clinical trials started and 118 clinical trials were completed, i.e. on average, 22.3% percent of trials that started reached the finish line to date. In the past 5 years, 225 clinical trials started and 86 clinical trials were completed. i.e. 38.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University College London Hospital" #1 sponsor was "University College, London" with 139 trials, followed by "University College London Hospitals" with 29 trials sponsored, "Hoffmann-La Roche" with 28 trials sponsored, "Janssen Research & Development, LLC" with 24 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 24 trials sponsored. Other sponsors include 497 different institutions and companies that sponsored additional 259 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University College London Hospital" #1 collaborator was "Cancer Research UK" with 44 trials as a collaborator, "University College London Hospitals" with 41 trials as a collaborator, "AstraZeneca" with 24 trials as a collaborator, "University College, London" with 16 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 12 trials as a collaborator. Other collaborators include 618 different institutions and companies that were collaborators in the rest 379 trials.

According to Clinical.Site data, the most researched conditions in "University College London Hospital" are "Prostate Cancer" (40 trials), "Ovarian Cancer" (25 trials), "Multiple Myeloma" (21 trials), "Breast Cancer" (20 trials) and "Fallopian Tube Cancer" (15 trials). Many other conditions were trialed in "University College London Hospital" in a lesser frequency.

Most popular intervention types in "University College London Hospital" are "Drug" (474 trials), "Other" (102 trials), "Procedure" (83 trials), "Biological" (69 trials) and "Device" (57 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (72 trials), "Cyclophosphamide" (19 trials), "Gemcitabine" (17 trials), "Dexamethasone" (16 trials) and "quality-of-life assessment" (16 trials). Other intervention names were less common.

The vast majority of trials in "University College London Hospital" are 600 trials for "All" genders, 70 trials for "Male" genders and 69 trials for "Female" genders.

Currently, there are 304 active trials in "University College London Hospital". 8 are not yet recruiting, 162 are recruiting, 126 are Active, not recruiting, and 8 are Enrolling by invitation. In total, there were 266 completed trials in University College London Hospital, 5 suspended trials, and 59 terminated clinical trials to date.

Out of the total trials that were conducted in University College London Hospital, 127 "Phase 1" clinical trials were conducted, 277 "Phase 2" clinical trials and 204 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 98 trials that are defined as “Not Applicable".

University College London Hospital has several departments that took part in Clinical trials: "The Heart Hospital" - 14 trials, "National Hospital for Neurology and Neurosurgery" - 85 trials, "UCLH Cancer Clinical Trials Unit" - 5 trials, "University College Hospital Macmillan Cancer Centre" - 4 trials, "Royal National Throat, Nose & Ear Hospital" - 3 trials, "Gastrointestinal Physiology Unit, University College London Hospital" - 2 trials, "University College Hospital; Department of Oncology" - 2 trials, "UCLH - Clinical Trials Pharmacy B&D Centre" - 2 trials